Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News This new HFCL tech could change internet connectivity forever—and it’s here now HFCL Limited has launched two Unlicensed Band Radio (UBR) products at the India Mobile Congress 2024 in New… byPallavi MadhirajuOctober 16, 2024